Cardiokol (קרדיוקול בע"מ)

Modi'in-Maccabim-Re'ut, Israel

Cardiokol is a privately-owned digital telehealth company that develops voice-based markers and methods for monitoring and screening heart rhythm disorders in large at-risk populations. We offer revolutionary affordable, scalable, long-term and age-friendly monitoring solutions. Our technology is applicable for mass at-risk populations including older adults (65+), by utilizing proprietary technology that is implemented in speech platforms such as landlines, smartphones, smart speakers and voice assistants.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Cardiokol (קרדיוקול בע"מ) on @MedStartr Today #CardiacRhythmHeartFailure #Arrhythmias #CardiovascularDisease #Cardiology #TelehealthVirtualCare #MedMo #MedStartrVentures

https://www.medstartr.ai/s/_W1lYrKtxS8

Get Involved in Cardiokol (קרדיוקול בע"מ)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2017
Website: www.cardiokol.com

Disease Areas

Cardiac Rhythm & Heart Failure Arrhythmias Cardiovascular Disease Cardiology

Technologies

Voice Digital Assistant User InterfaceBiomarkersRemote MonitoringDigital Health

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Cardiokol (קרדיוקול בע"מ)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.